GAM Holding’s Emergent Biosolutions EBS Stock Holding History

GAM Holding’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,847	Closed	-$447K	–	879
2019 Q1	$447K	Buy	8,847 +1,595	+22%	+$94.1K	0.02%	649
2018 Q4	$426K	Buy	+7,252	New	+$468K	0.02%	575
2018 Q3	–	Sell	-9,899	Closed	-$500K	–	899
2018 Q2	$500K	Buy	+9,899	New	+$516K	0.02%	665

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

GAM Holding's EBS Position: Q2 2019 in Review

GAM Holding sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 8,847 shares — an estimated $447K sold.

GAM Holding first reported a position in EBS in Q2 2018 and held it in 3 quarters. The position peaked at $500K in Q2 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

GAM Holding reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
GAM Holding sold 8,847 Emergent Biosolutions shares in Q2 2019, an estimated $447K.
GAM Holding first reported a position in Emergent Biosolutions in Q2 2018 and held it in 3 quarters.
GAM Holding's Emergent Biosolutions position peaked at $500K in Q2 2018.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on GAM Holding's 13F filing for Q2 2019, filed 12 Aug 2019.